簇集素中和脓毒症中细胞外组蛋白的炎症与细胞毒性作用
本研究探讨簇集素(CLU)能否对抗细胞外组蛋白的有害作用。方法上检测脓毒症患者的 CLU 与组蛋白表达,并在体外实验和实验性脓毒症体内模型中评估 CLU 对组蛋白的保护作用。结果显示 CLU 可结合循环组蛋白,降低其炎症、血栓和细胞毒性;脓毒症患者血浆 CLU 水平下降,非存活者下降幅度更大、持续时间更长;CLU 缺乏与小鼠脓毒症和内毒素血症模型死亡率增加相关;补充 CLU 改善小鼠脓毒症模型存活。结论认为 CLU 是内源性组蛋白中和分子,在广泛细胞死亡的病理状态下,补充 CLU 可能改善疾病耐受和宿主存活。
要点
- 脓毒症患者血浆 CLU 水平下降,非存活者较存活者下降幅度更大且更持久。
- CLU 可结合循环组蛋白,降低其炎症、血栓和细胞毒性特性。
- CLU 缺乏与小鼠脓毒症和内毒素血症模型死亡率增加相关。
- 补充 CLU 可改善小鼠脓毒症模型的存活。
- 作者认为在广泛细胞死亡的病理状态下,补充 CLU 可能改善疾病耐受和宿主存活。
适用人群与场景
- 脓毒症患者(检测血浆 CLU 与组蛋白表达)
- 小鼠脓毒症模型和内毒素血症模型(实验性脓毒症体内模型)
研究设计与关键结果
- 研究类型:体外实验与体内实验性脓毒症模型研究,并检测脓毒症患者 CLU 与组蛋白表达。
- CLU 可结合循环组蛋白,降低其炎症、血栓和细胞毒性特性。
- 脓毒症患者血浆 CLU 水平下降,非存活者下降幅度更大且更持久。
- CLU 缺乏与小鼠脓毒症和内毒素血症模型死亡率增加相关。
- 补充 CLU 改善小鼠脓毒症模型的存活。
证据类型、等级与局限
- 证据类型:体外实验、动物实验及患者样本观察。
- 局限:原文未报告局限性
对床旁实践的改变
- 作者认为,在广泛细胞死亡的病理状态下,补充 CLU 可能改善疾病耐受和宿主存活。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
Rationale: Extracellular histones, released into the surrounding environment during extensive cell death, promote inflammation and cell death, and these deleterious roles have been well documented in sepsis. Clusterin (CLU) is a ubiquitous extracellular protein that chaperones misfolded proteins and promotes their removal. Objectives: We investigated whether CLU could protect against the deleterious properties of histones. Methods: We assessed CLU and histone expression in patients with sepsis and evaluated the protective role of CLU against histones in in vitro assays and in vivo models of experimental sepsis. Measurements and Main Results: We show that CLU binds to circulating histones and reduces their inflammatory, thrombotic, and cytotoxic properties. We observed that plasma CLU levels decreased in patients with sepsis and that the decrease was greater and more durable in nonsurvivors than in survivors. Accordingly, CLU deficiency was associated with increased mortality in mouse models of sepsis and endotoxemia. Finally, CLU supplementation improved mouse survival in a sepsis model. Conclusions: This study identifies CLU as a central endogenous histone-neutralizing molecule and suggests that, in pathologies with extensive cell death, CLU supplementation may improve disease tolerance and host survival.
参考来源
- Augusto JF, Beauvillain C, Poli C, et al. Clusterin Neutralizes the Inflammatory and Cytotoxic Properties of Extracellular Histones in Sepsis. Am J Respir Crit Care Med. 2023. PMID: 37141109. doi:10.1164/rccm.202207-1253OC
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。